February 3, 2026 — INCATE (INCubator for Antibacterial Therapies in Europe), the antimicrobial incubator supporting the advancement of early stage anti-infectives, today announced a defining milestone in its institutional journey with the appointment of Holger [...]
More news
Every year, selecting the finalists for the Startup Pitch Event becomes more challenging, and 2026 [...]
January 21, 2026 – The Japan Pharmaceutical Manufacturers Association (JPMA) has joined forces with INCATE [...]
January 13, 2026 — INCATE (INCubator for Antibacterial Therapies in Europe), the antimicrobial incubator supporting [...]
Just before turning the page to 2026, it’s worth pausing to reflect on both the [...]
The INCATE Management team is happy to announce the release of INCATE’s first report, covering [...]
A collaborative research program led by the Helmholtz Centre for Infection Research (HZI) in Braunschweig, [...]
Couldn’t make it to our latest Entrepreneurs Club session, or want to revisit the discussion? [...]
The INCATE Team is happy to share some exciting news: the INCATE Selection Committee has [...]
